Approval · Notice of Compliance 24867 · 2020
KEPPRA: Notice of Compliance 24867
Issued December 22, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 24867
- Date
- December 22, 2020
- Company
- Ucb Canada IncOakville, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Labelling Only
- Reason
- Updates to the product monograph
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| KEPPRA | Not yet assigned | — |
Medicinal ingredients
- LEVETIRACETAM 250 MG per TAB
- LEVETIRACETAM 500 MG per TAB
- LEVETIRACETAM 750 MG per TAB